Enzymatic antibody modification by bacterial transglutaminase

Methods in Molecular Biology

Volumn 1045, Issue , 2013, Pages 205-215

  Dennler, Patrick ^a   Schibli, Roger ^a   Fischer, Eliane ^a  

^a ETH Zurich   (Switzerland)

Author keywords

Antibody conjugation; Antibody modification; Antibody drug conjugates; Bacterial transglutaminase; BTGase; Enzymatic conjugation; Mass spectrometry; Site specific; Stoichiometric

Indexed keywords

ANTIBODY CONJUGATE; BACTERIAL ENZYME; CADAVERINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ARTICLE; CONTROLLED STUDY; DETERIORATION; ENZYME ACTIVITY; ENZYME MODIFICATION; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; SITE DIRECTED MUTAGENESIS;

BACTERIA (MICROORGANISMS);

EID: 84934439122     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-541-5_12     Document Type: Article

References (11)

1. Junutula JR, Flagella KM, Graham RA, Parsons KL, Ha E, Raab H, Bhakta S, Nguyen T, Dugger DL, Li G, Mai E, Lewis Phillips GD, Hiraragi H, Fuji RN, Tibbitts J, Vandlen R, Spencer SD, Scheller RH, Polakis P, Sliwkowski MX (2010) Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer. Clin Cancer Res 16(19):4769-4778
2. Junutula JR, RaabH, Clark S, Bhakta S, Leipold DD,Weir S, Chen Y, Simpson M, Tsai SP, DennisMS, Lu Y, Meng YG, Ng C, Yang J, Lee CC, Duenas E,Gorrell J, KattaV,KimA,McDorman K, Flagella K, Venook R, Ross S, Spencer SD, Lee WW, Lowman HB, Vandlen R, Sliwkowski MX, Scheller RH, Polakis P, Mallet W (2008) Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.Nat Biotechnol 26(8):925-932
3. Sunbul M, Yin J (2009) Site specific protein labeling by enzymatic posttranslational modification. Org Biomol Chem 7(17):3361-3371
4. Rabuka D (2010) Chemoenzymatic methods for site-specific protein modification. Curr Opin Chem Biol 14(6):790-796
5. Boeggeman E, Ramakrishnan B, Pasek M, Manzoni M, Puri A, Loomis KH, Waybright TJ, Qasba PK (2009) Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: Application for cell surface antigen detection. Bioconjug Chem 20(6): 1228-1236
6. Solomon B, Koppel R, Schwartz F, Fleminger G (1990) Enzymic oxidation of monoclonal antibodies by soluble and immobilized bifunctional enzyme complexes. J Chromatogr 510: 321-329
7. Jeger S, Zimmermann K, Blanc A, Grunberg J, Honer M, Hunziker P, Struthers H, Schibli R (2010) Site-specific and stoichiometric modification of antibodies by bacterial transglutaminase. Angew Chem Int Ed Engl 49(51): 9995-9997
8. Mindt TL, Jungi V, Wyss S, Friedli A, Pla G, Novak-Hofer I, Grunberg J, Schibli R (2008) Modification of different IgG1 antibodies via glutamine and lysine using bacterial and human tissue transglutaminase. Bioconjug Chem 19 (1):271-278
9. Mehta K, Eckert R (2005) Transglutaminases: Family of enzymes with diverse functions, vol 38. Progress in experimental tumor research. Karger, Basel
10. Fontana A, Spolaore B, Mero A, Veronese FM (2008) Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase. Adv Drug Deliv Rev 60 (1):13-28
11. Knogler K, Grunberg J, Novak-Hofer I, Zimmermann K, Schubiger PA (2006) Evaluation of 177Lu-DOTA-labeled aglycosylated monoclonal anti-L1-CAM antibody chCE7: Influence of the number of chelators on the in vitro and in vivo properties. Nucl Med Biol 33(7):883-889